Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

General Electric Company (GE), Facebook Inc (FB), Intel Corporation (INTC), Pfizer Inc. (PFE): Some Mainstream Stocks on Monday

Editor’s note: Related tickers: General Electric Company (NYSE:GE), Facebook Inc (NASDAQ:FB), Intel Corporation (NASDAQ:INTC), Pfizer Inc. (NYSE:PFE), SINA Corp (NASDAQ:SINA)

The leaders on the markets are very important to be followed, since there are several thousands of companies listed and it is hard to track all of them. The leaders in terms of volume are particularly important, because they reflect stocks which have the largest coverage and are the “stars” of the markets, so to speak. On Monday among these stocks are situated: General Electric Company (NYSE:GE), Facebook Inc (NASDAQ:FB), Intel Corporation (NASDAQ:INTC), Pfizer Inc. (NYSE:PFE), and SINA Corp (NASDAQ:SINA).

General Electric Company (NYSE:GE)

General Electric Company (NYSE:GE) picked down by 0.34% to $22.14 in deals worth $17.7 million. According to the New York Times, the lending arm of the General Electric Company (NYSE:GE), GE Capital has halted its consumer financing programs to retailers specialized in selling guns. “The lending cutoff applies only to retailers whose primary business is selling guns,” New York Times quoted spokesman, Russell Wilkerson.

Facebook Inc (NASDAQ:FB)‘s turnover amounted to almost $16.5 million, while the stock added 0.97% to $27.11. According to a filing with the Securities and Exchange Commission (SEC) issued on April 26, in the first quarter of 2012, the compensation committee accepted a request from Facebook Inc (NASDAQ:FB)’s CEO, Mark Zuckerberg to reduce his base salary to $1 per year, which began on January 1, 2013.

With a turnover of slightly above $15.9 million, Intel Corporation (NASDAQ:INTC) has appreciated by 1.54% to $23.76. According to an article in Intel Newsroom, Intel Corporation (NASDAQ:INTC) will release the fourth generation of the Intel Core processor family. “The new family of processors will surpass old technology expectations and usher in a host of striking new designs with incredible performance and extraordinarily long battery life,” the article also said.

Next on the list is Pfizer Inc. (NYSE:PFE), which gained 1.33% to $30.49 in deals worth $12.6 million. In a press release issued today, Merck & Co., Inc. (NYSE: MRK) said that it has reached a collaboration agreement with Pfizer Inc. (NYSE:PFE), under which both Merck & Co., Inc. (NYSE: MRK) and Pfizer will work on Pfizer Inc. (NYSE:PFE)’s ertugliflozin (PF-04971729), “an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes.” “We are pleased to join forces with Merck in the battle against type 2 diabetes and the burden that it poses on global health, […] Through this collaboration, we believe we can build on Merck’s leadership position in diabetes care with the introduction of ertugliflozin, an innovative SGLT2 inhibitor discovered by Pfizer scientists,” the statement quoted the president and general manager of Pfizer Primary Care, John Young.

SINA Corp (NASDAQ:SINA) advanced by 10.32% to $55.49 in turnover worth almost $12.3 million.  SINA Corp (NASDAQ:SINA) said today in a statement that it will form a strategic alliance between several entities affiliated with SINA Corp (NASDAQ:SINA) and some entities associated with Alibaba Group to look into social commerce and create innovative marketing solutions. The alliance is expected to bring about $380 millions in revenues from advertising and social commerce services.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!